1281 related articles for article (PubMed ID: 23727436)
1. BDNF in fragile X syndrome.
Castrén ML; Castrén E
Neuropharmacology; 2014 Jan; 76 Pt C():729-36. PubMed ID: 23727436
[TBL] [Abstract][Full Text] [Related]
2. BDNF and TrkB in neuronal differentiation of Fmr1-knockout mouse.
Louhivuori V; Vicario A; Uutela M; Rantamäki T; Louhivuori LM; Castrén E; Tongiorgi E; Akerman KE; Castrén ML
Neurobiol Dis; 2011 Feb; 41(2):469-80. PubMed ID: 21047554
[TBL] [Abstract][Full Text] [Related]
3. BDNF-induced local protein synthesis and synaptic plasticity.
Leal G; Comprido D; Duarte CB
Neuropharmacology; 2014 Jan; 76 Pt C():639-56. PubMed ID: 23602987
[TBL] [Abstract][Full Text] [Related]
4. microRNAs and Fragile X Syndrome.
Lin SL
Adv Exp Med Biol; 2015; 888():107-21. PubMed ID: 26663181
[TBL] [Abstract][Full Text] [Related]
5. BDNF mechanisms in late LTP formation: A synthesis and breakdown.
Panja D; Bramham CR
Neuropharmacology; 2014 Jan; 76 Pt C():664-76. PubMed ID: 23831365
[TBL] [Abstract][Full Text] [Related]
6. Fragile X-like behaviors and abnormal cortical dendritic spines in cytoplasmic FMR1-interacting protein 2-mutant mice.
Han K; Chen H; Gennarino VA; Richman R; Lu HC; Zoghbi HY
Hum Mol Genet; 2015 Apr; 24(7):1813-23. PubMed ID: 25432536
[TBL] [Abstract][Full Text] [Related]
7. Delayed Maturation of Fast-Spiking Interneurons Is Rectified by Activation of the TrkB Receptor in the Mouse Model of Fragile X Syndrome.
Nomura T; Musial TF; Marshall JJ; Zhu Y; Remmers CL; Xu J; Nicholson DA; Contractor A
J Neurosci; 2017 Nov; 37(47):11298-11310. PubMed ID: 29038238
[TBL] [Abstract][Full Text] [Related]
8. Reduction of BDNF expression in Fmr1 knockout mice worsens cognitive deficits but improves hyperactivity and sensorimotor deficits.
Uutela M; Lindholm J; Louhivuori V; Wei H; Louhivuori LM; Pertovaara A; Akerman K; Castrén E; Castrén ML
Genes Brain Behav; 2012 Jul; 11(5):513-23. PubMed ID: 22435671
[TBL] [Abstract][Full Text] [Related]
9. Fragile X mice: reduced long-term potentiation and N-Methyl-D-Aspartate receptor-mediated neurotransmission in dentate gyrus.
Yun SH; Trommer BL
J Neurosci Res; 2011 Feb; 89(2):176-82. PubMed ID: 21162125
[TBL] [Abstract][Full Text] [Related]
10. Activity-dependent alterations in the sensitivity to BDNF-TrkB signaling may promote excessive dendritic arborization and spinogenesis in fragile X syndrome in order to compensate for compromised postsynaptic activity.
Kim SW; Cho KJ
Med Hypotheses; 2014 Oct; 83(4):429-35. PubMed ID: 25113167
[TBL] [Abstract][Full Text] [Related]
11. Impaired activity-dependent FMRP translation and enhanced mGluR-dependent LTD in Fragile X premutation mice.
Iliff AJ; Renoux AJ; Krans A; Usdin K; Sutton MA; Todd PK
Hum Mol Genet; 2013 Mar; 22(6):1180-92. PubMed ID: 23250915
[TBL] [Abstract][Full Text] [Related]
12. Impaired bidirectional NMDA receptor dependent synaptic plasticity in the dentate gyrus of adult female Fmr1 heterozygous knockout mice.
Yau SY; Bostrom CA; Chiu J; Fontaine CJ; Sawchuk S; Meconi A; Wortman RC; Truesdell E; Truesdell A; Chiu C; Hryciw BN; Eadie BD; Ghilan M; Christie BR
Neurobiol Dis; 2016 Dec; 96():261-270. PubMed ID: 27659109
[TBL] [Abstract][Full Text] [Related]
13. Rescue of NMDAR-dependent synaptic plasticity in Fmr1 knock-out mice.
Bostrom CA; Majaess NM; Morch K; White E; Eadie BD; Christie BR
Cereb Cortex; 2015 Jan; 25(1):271-9. PubMed ID: 23968838
[TBL] [Abstract][Full Text] [Related]
14. Increased coupling of caveolin-1 and estrogen receptor α contributes to the fragile X syndrome.
Yang Q; Yang L; Zhang K; Guo YY; Liu SB; Wu YM; Li XQ; Song Q; Zhuo M; Zhao MG
Ann Neurol; 2015 Apr; 77(4):618-36. PubMed ID: 25611593
[TBL] [Abstract][Full Text] [Related]
15. Mechanism-based treatments in neurodevelopmental disorders: fragile X syndrome.
Berry-Kravis E
Pediatr Neurol; 2014 Apr; 50(4):297-302. PubMed ID: 24518745
[TBL] [Abstract][Full Text] [Related]
16. Analysis of FMR1 deletion in a subpopulation of post-mitotic neurons in mouse cortex and hippocampus.
Amiri A; Sanchez-Ortiz E; Cho W; Birnbaum SG; Xu J; McKay RM; Parada LF
Autism Res; 2014 Feb; 7(1):60-71. PubMed ID: 24408886
[TBL] [Abstract][Full Text] [Related]
17. Enhanced endocannabinoid signaling elevates neuronal excitability in fragile X syndrome.
Zhang L; Alger BE
J Neurosci; 2010 Apr; 30(16):5724-9. PubMed ID: 20410124
[TBL] [Abstract][Full Text] [Related]
18. ICAM5 as a Novel Target for Treating Cognitive Impairment in Fragile X Syndrome.
Pei YP; Wang YY; Liu D; Lei HY; Yang ZH; Zhang ZW; Han M; Cheng K; Chen YS; Li JQ; Cheng GR; Xu L; Wu QM; McClintock SM; Yang Y; Zhang Y; Zeng Y
J Neurosci; 2020 Feb; 40(6):1355-1365. PubMed ID: 31882402
[TBL] [Abstract][Full Text] [Related]
19. Selective Deletion of Astroglial FMRP Dysregulates Glutamate Transporter GLT1 and Contributes to Fragile X Syndrome Phenotypes In Vivo.
Higashimori H; Schin CS; Chiang MS; Morel L; Shoneye TA; Nelson DL; Yang Y
J Neurosci; 2016 Jul; 36(27):7079-94. PubMed ID: 27383586
[TBL] [Abstract][Full Text] [Related]
20. Translational endpoints in fragile X syndrome.
de Esch CE; Zeidler S; Willemsen R
Neurosci Biobehav Rev; 2014 Oct; 46 Pt 2():256-69. PubMed ID: 24184744
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
